A current review has discussed how to build lung cancer screening programmes sustainable – not only in terms of costs…
Read More
Igniting alter in cancer screening: Alumnus Dr. Efraín Torres’ entrepreneurial journey to servant leadership
Few fires burn as fiercely as the one driving Dr. Efraín Torres, a 2019 Marquette biomedical engineering alumnus and CEO…
Read More
Meet Surbhi Sarna: Indian-origin founder who built a $275 million cancer detection startup after her teenage health struggles |
When Surbhi Sarna was a teenager dealing with painful ovarian cysts, she came face-to-face with a troubling gap in modern…
Read More
Sought-after Danish biotech secures head start with cancer drug candidate in the US
I want to receive customized email newsletters from Watch Medier A/S , including information about our brands and group companies…
Read More
AI co NudgeBee secures funding; Startups reimagining breast cancer treatment in India
Hello, After sparking concerns in the US and Europe over its potential apply to destabilise banking systems, Anthropic’s frontier AI…
Read More
Helsinki’s Algorithmiq wins €1.7 million prize for quantum-enabled light-sensitive cancer drug discovery
Algorithmiq, a Helsinki-based quantum software company, has become the sole winner of a €1.7 million ($2 million) prize from Wellcome…
Read More
STORM Therapeutics raises €47.5 million Series C to harness the power of RNA modification to treat cancer
STORM Therapeutics (STORM), a Cambridge-based BioTech company tarreceiveing RNA modifications to reprogram cells and develop novel cancer therapies, today announced…
Read More
Do All Patients in Europe Have Equal Acess to Cancer Clinical Trials? – ESMO
European Society for Medical Oncology (ESMO), shared a post on LinkedIn: “Do all patients in Europe have equal access to…
Read More
Gustavo Monnerat: New Lancet Regional Health Europe Series on Where Cancer Therapy May Be Heading
Gustavo Monnerat, Deputy Editor at The Lancet, shared a post on LinkedIn: “A new Lancet Regional Health – Europe series…
Read More
Utrecht’s Laigo Bio completes final close of €17 million Seed round to advance cancer and autoimmune therapies
Laigo Bio, a Utrecht-based BioTech firm focapplyd on protein degradation for tarreceiveed therapies, has concluded the second close of its…
Read More
